Latest News about PFE
Recent news which mentions PFE
Is Moderna a Good Healthcare Stock to Buy Now?
Today 8:34 EDT
From Motley Fool
2 Top Biotech Stocks to Buy in October
Today 6:05 EDT
From Motley Fool
2 Bargain Stocks You Can Buy Today and Hold Forever
Today 6:00 EDT
From Motley Fool
Can Pfizer and GlaxoSmithKline Beat Johnson & Johnson's RSV Vaccine?
October 17, 2021
From Motley Fool
Is Ocugen Stock Heading for a Crash?
October 17, 2021
From Motley Fool
Can This COVID Vaccine Stock Help Make You Rich?
October 16, 2021
From Motley Fool
Benzinga's Bulls And Bears Of The Week: Coinbase, Netflix, PayPal, Pfizer, Tesla And More
October 16, 2021
From Benzinga
From Motley Fool
2 Top Healthcare Stocks That Could Be Bought Out in 2022
October 16, 2021
From Motley Fool
3 COVID-19 Pill Stocks to Watch
October 16, 2021
From Motley Fool
3 No-Brainer Biotech Stocks to Buy Right Now
October 16, 2021
From Motley Fool
Better COVID-19 Stock: Merck or Pfizer?
October 16, 2021
From Motley Fool
Is The Pullback In Moderna's Stock A Buying Opportunity?
October 15, 2021
From Benzinga
FDA committee says it’s safe for all adults who got J&J’s COVID-19 vaccine to get a booster
October 15, 2021
From MarketWatch
The Daily Biotech Pulse: Moderna's Booster Shot Gets FDA Panel Backing, Decision Day For Avadel, Silence Therapeutics Strikes Licensing Deal, MiNK IPO
October 15, 2021
From Benzinga
Pfizer's Next mRNA Vaccine Candidate Goes Beyond COVID-19
October 15, 2021
From Motley Fool
3 Top Stocks Under $100
October 15, 2021
From Motley Fool
Could Johnson & Johnson's Booster Opportunity Be Better Than Pfizer's and Moderna's?
October 15, 2021
From Motley Fool
Cathie Wood Just Bought Shares of This Vaccine Underdog. Should You?
October 15, 2021
From Motley Fool
Why Moderna Stock Trounced the Market Today
October 14, 2021
From Motley Fool
The success of Merck’s antiviral—and other COVID-19 pills in development—may depend on how quickly people start taking them
October 14, 2021
From MarketWatch
2 Stocks to Consider if Pfizer's and Moderna's CEOs Are Right That the Pandemic Could End Next Year
October 14, 2021
From Motley Fool
Pfizer Just Scored Another Key Regulatory Approval
October 14, 2021
From Motley Fool
From Motley Fool
The Short And Long-Term Outlook For Moderna's Stock
October 13, 2021
From Benzinga
7 Foreign Stocks All U.S. Investors Should Be Watching
October 13, 2021
From InvestorPlace
Why Moderna Stock Is Popping Today
October 13, 2021
From Motley Fool
Americans are losing trust in Biden’s handling of the pandemic: poll
October 13, 2021
From MarketWatch
Can Pfizer Beat Moderna in mRNA Vaccines?
October 13, 2021
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.